Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

HPM: Another product in your portfolio, which uses the popular compound, Semaglutide ... ability of our trials to demonstrate safety and efficacy of our product candidates, and other positive ...

Ubisoft's Assassin's Creed Shadows has been rated for the Nintendo Switc 2 in Europe by Pan European Game Information (PEGI). A Switch 2 version of the game has yet to be announced by Ubisoft ...

Commenting on the news, Leerink said that the once-daily oral GLP-1 pill showed similar efficacy and safety relative to weekly injectable semaglutide, made by Novo Nordisk (NVO). Discover ...

After detailed deliberation, the committee recommended conducting a clinical trial in India to establish the safety and efficacy of Semaglutide tablets 1.5 mg, 4 mg, and 9 mg of the new formulation in ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily weight loss pill, orforglipron, demonstrated effectiveness consistent with ...

"These orforglipron T2D Ph3 efficacy results compare favorably cross-trial to NVO’s injectable semaglutide; the caveat is that neither semaglutide trial is a perfect comp," Leerink Partners ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 ... 18% and 20% of patients on the oral GLP-1 drug. For comparison, Novo reported rates of nausea and diarrhea ...

The group called Thursday’s findings a “positive readout” for orforglipron, adding that “Lilly achieves goal of reaching injectable like efficacy from oral orforglipron ... tirzepatide and Novo ...